Ismail Abbas Banderker

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Study protocol for a phase 2A trial of the safety and tolerability of increased dose rifampicin and adjunctive linezolid, with or without aspirin, for HIV-associated tuberculous meningitis [LASER-TBM]”.

Study protocol for a phase 2A trial of the safety and tolerability of increased dose rifampicin and adjunctive linezolid, with or without aspirin, for HIV-associated tuberculous meningitis [LASER-TBM]

Wellcome Open Research(2021)10.12688/wellcomeopenres.16783.1

N/A

0.554DataRank · unranked

13 citations

Sean Wasserman, Mpumi Maxebengula, Cari Stek, Marise Bremer, Remy Daroowala +33 more

A phase 2A trial of the safety and tolerability of increased dose rifampicin and adjunctive linezolid, with or without aspirin, for HIV-associated tuberculous meningitis (The LASER-TBM Trial)

medRxiv(2022)10.1101/2022.07.26.22278065

N/A

0DataRank · unranked

3 citations

Sean Wasserman, Cari Stek, Mpumi Maxebengula, Chen Liang, Stephani Stegmann +27 more